Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That’s why a small cadre of patients known as elite…
Comments closedAuthor: jcohen
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That’s why a small cadre of patients known as elite…
Comments closedStory by Jon Cohen; graphics by Nirja Desai. This story introduces Science‘s CRISPR in China series, supported by the Pulitzer Center. For many people, CRISPR plus…
Comments closedThis story, one in a series, was supported by the Pulitzer Center. Since the gene-edited babies known as Lulu and Nana became international news in…
Comments closedThis story, one in a series, was supported by the Pulitzer Center. On 10 June 2017, a sunny and hot Saturday in Shenzhen, China, two…
Comments closedThis story, one in a series, was supported by the Pulitzer Center. BEIJING, GUANGZHOU, JIANGMEN, KUNMING, AND SHANGHAI—Early one February morning, researchers harvest six eggs…
Comments closedThis story, the first in a series on CRISPR in China, was supported by the Pulitzer Center. BEIJING AND DURHAM, NORTH CAROLINA—If Gao Caixia were…
Comments closedPeople not infected with HIV can take a daily pill to prevent themselves from contracting the virus, a proven strategy called pre-exposure prophylaxis (PrEP). But…
Comments closedThe high-profile patent fight over who invented a key feature of the genome editor CRISPR has been resurrected. The 3-year-old battle, which a U.S. appeals court appeared…
Comments closed